FDA Panel Votes to Remove Long-Used Osteoporosis Drug Over Cancer Risk

Posted on April 23, 2013

Read Story

A panel of federal health experts says a long-established bone strengthening drug should no longer be used by women because there is little evidence it works and it may actually increase the risk of cancer.